GlassScriptPhysician profile
Eric R Culbertson
NPI 1134358104
$1,304.65
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $750 · 2022: $361 · 2024: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $193.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $438.60 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $177.37 | 2021 | |
| Linvatec Corporation | $135.40 | 2024 | Biobrace 23mm |
| Pfizer INC. | $123.31 | 2021 | |
| Nevro Corp. | $71.67 | 2022 | |
| Lilly USA, LLC | $69.46 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $59.54 | 2021 | |
| Scilex Pharmaceuticals INC. | $55.54 | 2021 | |
| Stryker Corporation | $29.38 | 2024 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Glenoid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.63 | 2021-2022 | |
| Ethicon US, LLC | $28.30 | 2024 | Stratafix, Vistaseal, Ethicon |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Stimwave Technologies Incorporated | $20.76 | 2022 | |
| Amgen INC. | $18.39 | 2022 | |
| Lundbeck LLC | $15.08 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Culbertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.